Covishield costs ₹300 per dose and Covaxin ₹400, govt. tells HC

‘Chief Minister has sought allocation of 910 MT oxygen’

The State government on Monday informed the High Court through a memo on the steps taken to arrest the spread of coronavirus that under the Liberalised Pricing and Accelerated National COVID-19 Vaccination Policy notified by the Centre, Bharat Biotech and Serum Institute of India are mandated to supply 50% of their production to the Centre at the rate of ₹150 per dose and half of the balance is to be supplied to States and the other half to private players. Although no price has been fixed for supply to the States, the Centre indicated in its affidavit filed in the Supreme Court that in ‘informal consultations’ with the manufacturers, it has been decided that both the manufacturers should supply vaccines to every State at a uniform rate. Consequently, while Covishield is available to the States at ₹300 per dose, Covaxin costs ₹400 per dose.